|
1
|
Purushotham AD, Lewison G and Sullivan R:
The state of research and development in global cancer surgery. Ann
Surg. 255:427–432. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao LQ, Chen XL, Wang Q, et al:
Upregulation of PTEN involved in rosiglitazone-induced apoptosis in
human hepatocellular carcinoma cells. Acta Pharmacol Sin.
28:879–887. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng X, Fang Z, Wu Y and Zhang H: Chemical
constituents of the fruits of Vitex trifolia L. Zhongguo
Zhong Yao Za Zhi. 21:167–168. 1911996.(In Chinese).
|
|
4
|
Haidara K, Zamir L, Shi QW and Batist G:
The flavonoid casticin has multiple mechanisms of tumor
cytotoxicity action. Cancer Lett. 242:180–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wojcinski S, Farrokh A, Hille U, et al:
The Automated Breast Volume Scanner (ABVS): initial experiences in
lesion detection compared with conventional handheld B-mode
ultrasound: a pilot study of 50 cases. Int J Womens Health.
3:337–346. 2011. View Article : Google Scholar
|
|
6
|
Zeng F, Tian L, Liu F, Cao J, Quan M and
Sheng X: Induction of apoptosis by casticin in cervical cancer
cells: reactive oxygen species-dependent sustained activation of
Jun N-terminal kinase. Acta Biochim Biophys Sin (Shanghai).
44:442–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Csupor-Loffler B, Hajdu Z, Zupko I, et al:
Antiproliferative effect of flavonoids and sesquiterpenoids from
Achillea millefolium s. l on cultured human tumour cell
lines. Phytother Res. 23:672–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobayakawa J, Sato-Nishimori F, Moriyasu M
and Matsukawa Y: G2-M arrest and antimitotic activity mediated by
casticin, a flavonoid isolated from Viticis Fructus (Vitex
rotundifolia Linne fil). Cancer Lett. 208:59–64. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Imai M, Kikuchi H, Denda T, Ohyama K,
Hirobe C and Toyoda H: Cytotoxic effects of flavonoids against a
human colon cancer derived cell line, COLO 201: a potential natural
anti-cancer substance. Cancer Lett. 276:74–80. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang J, Yang Y, Tian L, Sheng XF, Liu F
and Cao JG: Casticin-induced apoptosis involves death receptor 5
upregulation in hepatocellular carcinoma cells. World J
Gastroenterol. 17:4298–4307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Galili N, Davis RJ, Fredericks WJ, et al:
Fusion of a fork head domain gene to PAX3 in the solid tumour
alveolar rhabdomyosarcoma. Nat Genet. 5:230–235. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Anderson MJ, Viars CS, Czekay S, Cavenee
WK and Arden KC: Cloning and characterization of three human
forkhead genes that comprise an FKHR-like gene subfamily. Genomics.
47:187–199. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo S, Rena G, Cichy S, He X, Cohen P and
Unterman T: Phosphorylation of serine 256 by protein kinase B
disrupts transactivation by FKHR and mediates effects of insulin on
insulin-like growth factor-binding protein-1 promoter activity
through a conserved insulin response sequence. J Biol Chem.
274:17184–17192. 1999. View Article : Google Scholar
|
|
14
|
Medema RH, Kops GJ, Bos JL and Burgering
BM: AFX-like Forkhead transcription factors mediate cell-cycle
regulation by Ras and PKB through p27kip1. Nature. 404:782–787.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakamura N, Ramaswamy S, Vazquez F,
Signoretti S, Loda M and Sellers WR: Forkhead transcription factors
are critical effectors of cell death and cell cycle arrest
downstream of PTEN. Mol Cell Biol. 20:8969–8982. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu M, Ma J, Xue W, et al: The expression
and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma.
Pathol Oncol Res. 15:679–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fei M, Lu M, Wang Y, et al: Arsenic
trioxide-induced growth arrest of human hepatocellular carcinoma
cells involving FOXO3a expression and localization. Med Oncol.
26:178–185. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park TJ, Kim JY, Oh SP, et al: TIS21
negatively regulates hepatocarcinogenesis by disruption of cyclin
B1-Forkhead box M1 regulation loop. Hepatology. 47:1533–1543. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Ahmad A, Li Y, Banerjee S, Kong D
and Sarkar FH: Forkhead box M1 transcription factor: a novel target
for cancer therapy. Cancer Treat Rev. 36:151–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao XC, Tian L, Cao JG and Liu F:
Induction of apoptosis by 5,7-dihydroxy-8-nitrochrysin in breast
cancer cells: the role of reactive oxygen species and Akt. Int J
Oncol. 37:1345–1352. 2010.PubMed/NCBI
|
|
22
|
Yang XH, Zheng X, Cao JG, Xiang HL, Liu F
and Lv Y: 8-Bromo-7-methoxychrysin-induced apoptosis of
hepatocellular carcinoma cells involves ROS and JNK. World J
Gastroenterol. 16:3385–3393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu QF, Liu C, Tai MH, et al: Knockdown of
FoxM1 by siRNA interference decreases cell proliferation, induces
cell cycle arrest and inhibits cell invasion in MHCC-97H cells in
vitro. Acta Pharmacol Sin. 31:361–366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shankar S, Chen Q and Srivastava RK:
Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to
enhance antiangiogenic effects of EGCG through activation of FOXO
transcription factor. J Mol Signal. 3:72008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laoukili J, Stahl M and Medema RH: FoxM1:
at the crossroads of ageing and cancer. Biochim Biophys Acta.
1775:92–102. 2007.PubMed/NCBI
|
|
26
|
Krupczak-Hollis K, Wang X, Kalinichenko
VV, et al: The mouse Forkhead Box m1 transcription factor is
essential for hepatoblast mitosis and development of intrahepatic
bile ducts and vessels during liver morphogenesis. Dev Biol.
276:74–88. 2004. View Article : Google Scholar
|
|
27
|
Wonsey DR and Follettie MT: Loss of the
forkhead transcription factor FoxM1 causes centrosome amplification
and mitotic catastrophe. Cancer Res. 65:5181–5189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Laoukili J, Kooistra MR, Bras A, et al:
FoxM1 is required for execution of the mitotic programme and
chromosome stability. Nat Cell Biol. 7:126–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zeng J, Wang L, Li Q, et al: FoxM1 is
up-regulated in gastric cancer and its inhibition leads to cellular
senescence, partially dependent on p27 kip1. J Pathol. 218:419–427.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu M, Dai B, Kang SH, et al: FoxM1B is
overexpressed in human glioblastomas and critically regulates the
tumorigenicity of glioma cells. Cancer Res. 66:3593–3602. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Korver W, Roose J and Clevers H: The
winged-helix transcription factor Trident is expressed in cycling
cells. Nucleic Acids Res. 25:1715–1719. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Calvisi DF, Pinna F, Ladu S, et al:
Forkhead box M1B is a determinant of rat susceptibility to
hepatocarcinogenesis and sustains ERK activity in human HCC. Gut.
58:679–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yilmaz OH and Morrison SJ: The PI-3kinase
pathway in hematopoietic stem cells and leukemia-initiating cells:
a mechanistic difference between normal and cancer stem cells.
Blood Cells Mol Dis. 41:73–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Han CY, Cho KB, Choi HS, Han HK and Kang
KW: Role of FoxO1 activation in MDR1 expression in
adriamycin-resistant breast cancer cells. Carcinogenesis.
29:1837–1844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu Z and Tindall DJ: FOXOs, cancer and
regulation of apoptosis. Oncogene. 27:2312–2319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fernandez de Mattos S, Villalonga P,
Clardy J and Lam EW: FOXO3a mediates the cytotoxic effects of
cisplatin in colon cancer cells. Mol Cancer Ther. 7:3237–3246.
2008.PubMed/NCBI
|
|
37
|
Sunters A, Fernandez de Mattos S, Stahl M,
et al: FoxO3a transcriptional regulation of Bim controls apoptosis
in paclitaxel-treated breast cancer cell lines. J Biol Chem.
278:49795–49805. 2003. View Article : Google Scholar : PubMed/NCBI
|
